华中科技大学学报(医学版) ›› 2026, Vol. 55 ›› Issue (5): 674-679.doi: 10.3870/j.issn.1672-0741.25.09.040

• 实验研究 • 上一篇    下一篇

HMOX1调控铁死亡在子宫内膜异位症中的分子机制研究*

尹向梅, 马向英, 苏小娟, 孔祥凤, 谷丹青, 赵健△   

  1. 石家庄市人民医院妇科,石家庄 050000
  • 收稿日期:2025-09-22 发布日期:2026-10-30
  • 通讯作者: △E-mail:13122777375@163.com
  • 作者简介:尹向梅,女,1989年生,医学硕士,主治医师,E-mail:13472749251@163.com
  • 基金资助:
    *河北省卫生健康委员会医学科学研究课题计划项目(No. 20250204)

The Molecular Mechanism of HMOX1 Regulating Ferroptosis in Endometriosis

Yin Xiangmei, Ma Xiangying, Su Xiaojuan et al   

  1. Department of Gynecology, Shijiazhuang People' s Hospital, Shijiazhuang 050000, China
  • Received:2025-09-22 Published:2026-10-30
  • Contact: △E-mail:13122777375@163.com

摘要: 目的 探讨血红素加氧酶-1(HMOX1)调控铁死亡在子宫内膜异位症中的分子机制。方法 人永生化子宫异位内膜上皮细胞系(hEM15A)分为空白(Con)组、sh-NC组、sh-HMOX1组。其中,sh-NC组、sh-HMOX1组hEM15A转染HMOX1的阴性对照和干扰质粒。正常人子宫内膜基质细胞(hESCs)分为空白(Con)组、FeSO4组、FeSO4+sh-NC组、FeSO4+sh-HMOX1组。其中,FeSO4组、FeSO4+sh-NC组、FeSO4+sh-HMOX1组暴露于FeSO4(100 μmol/L)溶液中24 h。FeSO4+sh-NC组、FeSO4+sh-HMOX1组hESCs在暴露于FeSO4前转染HMOX1的阴性对照和干扰质粒。通过CCK-8实验检测细胞活力,流式细胞仪测定脂质过氧化,FeRhoNox-1荧光染色分析细胞中Fe2+水平,Transwell检测细胞迁移能力,人脐静脉内皮细胞(HUVECs)成管实验评估血管生成活性,免疫印迹法分析铁代谢相关蛋白质表达水平。结果 与hESCs相比,hEM15A细胞中HMOX1蛋白表达上调。与sh-NC组相比,sh-HMOX1组中hEM15A细胞活力、迁移细胞数、HUVECs管形成数、脂质过氧化、Fe2+水平、ACSL4蛋白表达水平降低(均P<0.05),SLC7A11、GPX4蛋白表达水平升高(均P<0.05)。与Con组相比,FeSO4组和FeSO4+sh-NC组hESCs细胞中脂质过氧化、Fe2+水平和HMOX1、ACSL4蛋白表达水平增加(均P<0.05),SLC7A11、GPX4蛋白表达水平降低(均P<0.05);与FeSO4+sh-NC组相比,FeSO4+sh-HMOX1组hESCs细胞中脂质过氧化、Fe2+水平和HMOX1、ACSL4蛋白表达水平降低(均P<0.05),SLC7A11、GPX4蛋白表达水平升高(均P<0.05)。与Con组相比,FeSO4组和FeSO4+sh-NC组hESCs细胞迁移细胞数、HUVECs管形成数增加(均P<0.05);与FeSO4+sh-NC组相比,FeSO4+sh-HMOX1组hESCs细胞的细胞活力、迁移细胞数和HUVECs管形成数降低(均P<0.05)。结论 HMOX1敲低可能通过调节铁死亡来抑制子宫内膜异位症的发展,这为HMOX1作为子宫内膜异位症的潜在靶点提供了新的证据。

关键词: 子宫内膜异位症, 铁死亡, 血红素加氧酶-1, 迁移, 血管生成

Abstract: Objective To investigate the molecular mechanism by which heme oxygenase-1 (HMOX1) regulates ferroptosis in endometriosis. Methods Human immortalized endometrial ectopic epithelial cells (hEM15A) were divided into blank control (Con) group, sh-NC group, and sh-HMOX1 group. The hEM15A cells in the sh-NC and sh-HMOX1 groups were transfected with negative control and interfering plasmids targeting HMOX1, respectively. Normal human endometrial stromal cells (hESCs) were divided into blank control (Con) group, FeSO4 group, FeSO4+sh-NC group, and FeSO4+sh-HMOX1 group. Cells in the FeSO4, FeSO4+sh-NC, and FeSO4+sh-HMOX1 groups were exposed to FeSO4 (100 μmol/L) solution for 24 hours. The hESCs in the FeSO4+sh-NC and FeSO4+sh-HMOX1 groups were transfected with negative control and interfering plasmids targeting HMOX1 prior to FeSO4 exposure. Cell viability was assessed using the Cell Counting Kit-8 (CCK-8) assay. Lipid peroxidation was measured by flow cytometry. Intracellular Fe²+ levels were analyzed by FeRhoNox-1 fluorescence staining. Cell migration ability was evaluated by Transwell assay, and pro-angiogenic activity was assessed by HUVECs tube formation assay. Expression of iron metabolism-related proteins was analyzed by Western blotting. Results Compared with hESCs, HMOX1 protein expression was upregulated in hEM15A cells. Compared with the sh-NC group, the sh-HMOX1 group exhibited decreased hEM15A cell viability, number of migrated cells, number of HUVEC tube formation,lipid ROS levels, Fe²+ levels, and ACSL4 protein expression (all P<0.05), while SLC7A11 and GPX4 protein expression was increased (both P<0.05). Compared with the Con group, the FeSO4 and FeSO4+sh-NC groups showed increased lipid ROS, Fe²+ levels, and HMOX1 and ACSL4 protein expression in hESCs (all P<0.05), whereas SLC7A11 and GPX4 protein expression was decreased (both P<0.05). Compared with the FeSO4+sh-NC group, the FeSO4+sh-HMOX1 group showed decreased lipid ROS, Fe²+ levels, and HMOX1 and ACSL4 protein expression in hESCs (all P<0.05), while SLC7A11 and GPX4 protein expression was increased (both P<0.05). Compared with the Con group, the FeSO4 and FeSO4+sh-NC groups exhibited increased numbers of migrated hESCs and HUVEC tube formation(all P<0.05). Compared with the FeSO4+sh-NC group, the FeSO4+sh-HMOX1 group showed decreased cell viability, number of migrated cells, and number of HUVEC tube formation in hESCs (all P<0.05). Conclusion Knockdown of HMOX1 may inhibit the progression of endometriosis by regulating ferroptosis, providing new evidence for HMOX1 as a potential therapeutic target for endometriosis.

Key words: endometriosis, ferroptosis, heme oxygenase-1, migration, angiogenesis

中图分类号: